COGT - Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.